GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senseonics Holdings Inc (AMEX:SENS) » Definitions » Gross Margin %

SENS (Senseonics Holdings) Gross Margin % : -95.03% (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Senseonics Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Senseonics Holdings's Gross Profit for the three months ended in Sep. 2024 was $-4.05 Mil. Senseonics Holdings's Revenue for the three months ended in Sep. 2024 was $4.26 Mil. Therefore, Senseonics Holdings's Gross Margin % for the quarter that ended in Sep. 2024 was -95.03%.


The historical rank and industry rank for Senseonics Holdings's Gross Margin % or its related term are showing as below:

SENS' s Gross Margin % Range Over the Past 10 Years
Min: -350.9   Med: -48.09   Max: 16.63
Current: -10.49


During the past 10 years, the highest Gross Margin % of Senseonics Holdings was 16.63%. The lowest was -350.90%. And the median was -48.09%.

SENS's Gross Margin % is ranked worse than
95.53% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 51.89 vs SENS: -10.49

Senseonics Holdings had a gross margin of -95.03% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Senseonics Holdings was 0.00% per year.


Senseonics Holdings Gross Margin % Historical Data

The historical data trend for Senseonics Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senseonics Holdings Gross Margin % Chart

Senseonics Holdings Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -91.30 -350.90 -5.93 16.63 13.81

Senseonics Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.22 13.56 6.64 6.13 -95.03

Competitive Comparison of Senseonics Holdings's Gross Margin %

For the Medical Devices subindustry, Senseonics Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senseonics Holdings's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Senseonics Holdings's Gross Margin % falls into.



Senseonics Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Senseonics Holdings's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=3.1 / 22.39
=(Revenue - Cost of Goods Sold) / Revenue
=(22.39 - 19.299) / 22.39
=13.81 %

Senseonics Holdings's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=-4.1 / 4.263
=(Revenue - Cost of Goods Sold) / Revenue
=(4.263 - 8.314) / 4.263
=-95.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Senseonics Holdings  (AMEX:SENS) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Senseonics Holdings had a gross margin of -95.03% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Senseonics Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Senseonics Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Senseonics Holdings Business Description

Traded in Other Exchanges
Address
20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Executives
Sharon Larkin director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Douglas A Roeder director 160 BOVET RD, SUITE 408, C/O DELPHI VENTURES, SAN MATEO CA 94402
Frederick T. Sullivan officer: Chief Financial Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Mukul Jain officer: VP Operations, Qual & Reg 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Edward Fiorentino director 1350 KENNICOTT DRIVE, LAKE FOREST IL 60045
Mirasol Panlilio officer: VP Global Sales & Marketing 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Timothy T Goodnow director, officer: President & Chief Exec Officer 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Francine Kaufman officer: Chief Medical Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Kenneth L Horton officer: GC & Corp. Development Advisor VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE MA 02139
Nick B. Tressler officer: Chief Financial Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 208786
Anthony R. Raab director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
John Marotta director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Stephen P Defalco director ONE EXETER STREET, BOSTON MA 02116
Douglas S Prince director 20 TILESTON STREET, PH4, BOSTON MA 02113
Edelman Steven director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876